Plasmodium vivax apical membrane antigen-1(PvAMA-1) is a surface protein with polymorphic sites. This study was aimed to analyze the polymorphic amino acid residues at PvAMA-1 in different infected age groups. 92 blood samples were collected from the south and southeast of Iran. The DNA coding for the domain I (DI), DII, and partial DIII of this antigen was amplified by Nested-PCR, and sequenced. Nucleotide mutations were found in 49 sites and based on the amino acid sequence, 30 variable sites were detected. Age distribution of malaria cases showed that the majority of the patients were between 10 to 30 years old. The scattering plot haplotypes by age showed an increasing incidence rate with age during childhood, whereas, incidence was the lowest in patients under five years old. Comparison of the polymorphic sites of PvAMA-1 in Iranian isolates with those found in other geographic regions of the world indicated nine common variable positions. In addition, a significant dependence was found between some particular substitutions and age categories. Dependence between particular substitutions and age groups suggests that certain residues in AMA-1 are responsible for clinical attacks in different ages, likely as a result of host immune pressure. The crystal structure of the PvAMA-1 showed that the amino acid substitutions that changed the protein charge were exclusively located in loops and turns where, the interactions with antibodies could occur. These data provide the necessary information for an AMA-1 based malaria vaccine design to be effective across all ages.
most prevalent form of malaria outside Africa (3).
Therefore, development of a vaccine against P.
vivax is a necessary priority, particularly due to increased resistance of this parasite to the antimalarial drugs such as chloroquine, primaquine and pyrimethamine (4) (5) (6) (7) . Identification of target antigens that induce protective immune response is a pre-requisite for vaccine development. Many reports indicate apical membrane antigen1 (AMA-1) as one of the promising malaria vaccine candidates (8) (9) (10) (11) . AMA-1 is a type I integral membrane protein found in most of the Plasmodium species (11) . AMA-1 expression is maximal in late schizogony during asexual reproduction in red blood cells (12, 13) . It is initially located in merozoite apical organelles, and after processing relocates to the surface of mature merozoite (14) . Around the time of erythrocyte invasion, the pro-sequence of AMA-1 is processed proteolytically by two c-terminal cleavages (15) . (19, 20) .
Antigenic diversity is supposed to be a major mechanism for the parasite to escape from the host immune system, but remains the greatest obstacle in designing a malaria vaccine. Some findings show that protective immunity against AMA-1 and MSP-1 (merozoite surface protein) has a high degree of strain specificity (22, 23) . Thus, AMA-1 polymorphism is a major problem to the efficacy of 
Materials and methods

Study area and sample collection
A total of 92 blood samples were collected from two different malaria endemic regions of Iran (5′-GTTGAGAGAAGCACACGAATG-3′) and
PvAMA2 (5′-GAGATAAATATCCTCGGCAGG-3′), and then the primary PCR product was used as template in a second round of PCR to amplify the internal 1000 bp region for which DI and DII are available, using the PvAMAF2 (5′-
TGCAGAAGTGGAAAATGCAAAG-3′) and
PvAMA4 (5′-CCATCAACACTGTACAGATTC-3′) primers. PCR cycles were performed as described previously (25) , and the data are available in the GenBank database under the accession numbers KF181626-KF181642, and KF422636-KF422681.
Sequence and statistical analyzes
Nucleotide and amino acid sequences were aligned by MEGA program (26) , with the Salvador-1 sequence (XM_001615397) as the reference strain. The haplotypes were classified based on the nucleotide sequences using DnaSP ver. 5. 10. 01 (27 
Results
pvama-1 mutations and haplotypes
Based on the sequencing data, a 911 bp (Table 1) .
Haplotypes association with age of infection
The number of malaria cases was highest in the 20-30 as well as 10-20 age groups ( Fig.1 1183  1176  1174  1172  1165  1158  1155  1154  1152  1151  1149  1148  1146  1145  1144  1138  1133  1125  1120  1106  1103  1092  1083  1078  1076  1075  1074  1068  1054  968  877  863  831 substitutions in DII of PvAMA-1 where they could affect the protein structure. Although, some amino acid substitutions with no effect on the protein charge were K120R, and D242E in AMA-1 DI.
PvAMA-1 variants
Identified patterns of the mutation are one of the most important strategies used by the malaria parasites to escape from the host immune system and should be considered for vaccine design.
Comparative analysis of the polymorphic sites in PvAMA-1 between Iranian isolates and those previously reported from the other malaria endemic areas (India, Thailand, Venezuela and Sri lanka) (28) (29) (30) (31) (32) revealed that 9 of these variable sites were common (Table 3) In order to evaluate the effect of polymorphic amino acid positions in the AMA-1 on age of infection, the rate of amino acid residues at mutation sites shared between Iran, India, Thailand, Venezuela and Sri Lanka was assessed. The results showed a strong association between the rate of amino acid residues Q and P in position 384, and clinical attacks in 30-40 age group. Similarly, P384, D107, K189, K190, and L384 positions were associated with malaria incidence in over 40 years (P<0.05, Table 4 ). Mapping of the amino acid substitutions on 3D structure of PvAMA-1 showed that mutations with changes in the charge of the protein were exclusively located in loop and turn secondary structures whereas, other mutation sites had been spread in the molecule (Fig. 3) .
Discussion
The present study was aimed to investigate the associations between the incidence of PvAMA-1 variants and age of infection.
The data show that the incidence of malaria reached the peak in the late teenage years, and declined with age in adulthood ( Table 2 ; Fig. 1 ). This age distribution confirms that in populations with low malaria transmission, the incidence increases with age in teenagers and then declines; whereas in areas exposed to a very low level of transmission or to epidemic malaria, the clinical attack occurs across all ages (33) . The decrease in malaria intensity with age in adults in the present study is in agreement with the study on P. falciparum in Kwazulu Natalin South Africa (34) , and another report on P. vivax infection by Denis-lozano et al. (35) in Mexico that can be explained by the low level of transmission intensity in these areas. Besides, adults may have had immunity early in life due to previous exposure to the malaria parasite. Our findings are in contrast with the report of Baird et al. (36) in Irian Jaya which showed an increase in malaria infection with age in a population of adults from Java after migration to a hyper endemic area. However, the examined population in the present study has been exposed to a lower level of transmission than the population in the Irian Java study. The scattering plot shows an increasing incidence rate with age (Table 3) .
Despite this, the Q277K replacement has not been found in Thai population that may be explained by the lower host immune selection pressure due to very low malaria incidence rate (30) and/or insufficient time to generate new alleles bearing this mutation. Moreover, some mutations involved in the amino acid changes with the same charge may be associated with functional constraints of the protein (K120R, D242E in AMA-1 Domain I) (Fig. 2 A) .
Comparison of the polymorphic positions between five different populations showed that 9 positions were common ( Table 3 ). The conservation of the common mutations suggests that these particular substitutions are necessary for the parasite to escape from the host immune system The polymorphic amino acid residues of each mutation site in the studied age groups were compared with that of the whole population by the two tailed Fisher exact test in Graph pad program.*: significant values with P<0.05;**: significant values with P< 0.0001
The distribution of polymorphic amino acid residues (common between 5 comparative regions) by age categories (Table 4) showed that residues E187 and E243 were strongly associated with malaria incidence in children under 10 years of age (21).
This strain-dependent incidence suggests that certain residues at particular positions decrease the AMA-1 immunogenicity, and a long exposure is necessary for inducing an effective immune response. These positions were assumed to be effective in controlling growth of the malaria parasite (21) .
Furthermore, these findings show that particular amino acid substitutions could be responsible for the clinical attacks in different age groups, and there is an age-related selection in the immune system against certain amino acids at particular positions of the parasite's AMA-1. In addition, the clinical presentation of the malaria infections is associated with different AMA-1 strains, suggesting that parasite factors are involved. Correspondingly, it was proposed that the higher morbidity in P. falciparum species could be related to the presence of certain residues in AMA-
1(21).
Concerning the effect of certain amino acid residues on malaria infection rates, we cannot determine if these residues affect directly or their cooperation with other AMA-1 residues involved. yet, as the amino acid residues associated with the clinical malaria cases occur in multiple AMA-1 sequences, few parasite transmission can be ruled out. Thus, it is improbable that the clinical attacks are due to a combination of particular residues in other loci.
Knowledge of the amino acid substitutions, particularly those with charge conversion, could help to recognize the main epitopes that elicit protective antibodies. In the present study, these substitutions were exclusively observed in turn and loop secondary structures of the antigen (Fig. 3) .
Turns and loops generally lie on the surface of the proteins where they can participate in interactions between proteins and other molecules such as antibodies (38, 39) .
The present study provides the necessary information to design a malaria vaccine to be effective in different age categories, and suggests that some of the epitopes in AMA-1 providing protective immunity response are strain specific.
This problem is one of the difficulties in designing efficient vaccine based on only one allelic form of the protein, and was confirmed by previous reports (17, 19, 22, 40) . 
